Bellevue Asset Management »

Cytokinetics shares owned by Bellevue Asset Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Bellevue Asset Management from 13F filings

Historical chart of Bellevue Asset Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Bellevue Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Bellevue Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0k 19 52.79
2024-06-30 $1.0k 19 54.16

More positions owned by Bellevue Asset Management

Microsoft Corporation (MSFT)
Apple (AAPL)
First Tr Exchng Traded Fd Vi Tcw Opportunis (FIXD)
First Tr Exchange- Traded Fst Low Oppt Etf (LMBS)
First Tr Mid Cap Core Alphad Com Shs (FNX)
Capital Group Growth Etf Shs Creation Uni (CGGR)
First Tr Exchange-traded Risng Divd Achiv (RDVY)
Starbucks Corporation (SBUX)
Costco Wholesale Corporation (COST)
Jp Morgan Exchange Traded F Intrnl Res Eqt (JIRE)
Amazon (AMZN)
Vanguard World Fds Inf Tech Etf (VGT)
Jp Morgan Exchange Traded F Equity Premium (JEPI)
First Tr Exchange-traded First Tr Enh New (FTSM)
Jp Morgan Exchange Traded F Nasdaq Eqt Prem (JEPQ)

View all positions for Bellevue Asset Management

Top funds holding Cytokinetics

BlackRock
BlackRock
Vanguard Group
T. Rowe Price Investment Management
State Street Corporation
Bank of America Corporation
T. Rowe Price Associates
Armistice Capital
Geode Capital Management
Pentwater Capital Management
Boxer Capital
Pictet Asset Management Holding SA
Alliancebernstein
Marshall Wace
Partner Fund Management

View all funds holding Cytokinetics